Bemiparin in the treatment of a patient with a habitual miscarriage


Cite item

Full Text

Abstract

Clinical observation is outlined - conducting pregnancy in a 43-year-old patient with low-risk thrombophilia, a habitual miscarriage, and venous thrombosis of cerebral vessels in an anamnesis. The results were obtained, indicating a favorable clinical outcome when the drug was administered in therapeutic doses, no side effects were recorded. It was possible to achieve the prolongation of pregnancy until the deadline in the absence of thrombotic and hemorrhagic complications. There were no thromboses during pregnancy and in the postpartum period, thrombocytopenia, bleeding in the II and III trimesters of pregnancy. At delivery, blood loss was 700 ml. Anticoagulant therapy with bemiparin was continued for 6 weeks postpartum period for the prevention of thrombotic complications.

About the authors

N K Tetruashvili

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: tetrauly@mail.ru
д-р мед. наук, рук. 2-го акушерского отд-ния патологии беременности 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

A A Agadzhanova

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: aagadjanova@mail.ru
д-р мед. наук, вед. науч. сотр. 2-го акушерского отд-ния патологии беременности 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

T B Ionanidze

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: teona_21@rambler.ru
науч. сотр. 2-го акушерского отд-ния патологии беременности 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

References

  1. Alalaf S, Jawad R, Muhammad P. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy and Childbirth 2015; 15: 7.
  2. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 37a. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. 2015.
  3. Макацария А.Д., Бицадзе В.О. Тромбофилические состояния в акушерской практике. М.: Russo, 2001.
  4. Alalaf S. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome. Arch Gynecol Obstet 2012; 285: 641-7.
  5. Guven D, Bakay K, Kocak I, Ozdemir A. Effectiveness of Bemiparin Sodium for Preventing Pregnancy Loss in Patients with MTHFR C677T Mutation and Habitual Abortus. Open J Obstet Gynecol 2014; 4: 930-4. http://dx.doi.org/10.4236/ojog.2014.415131
  6. Villa J, Marco A, Santamaria A. et al. Haemostasis and Thrombosis Unit, Haematology Service. Gynaecology and Obstetrics Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. 2006. The 2nd International symposium Women’s health issues in thrombosis and Haemostasis. Budapest, Hungary, Feb 4-6, 2005.
  7. Ciccone M.M, Corbo F, Corrales N.E. et al. Review: Bemiparin, an effective and safe low molecular weight heparin: A review. Vascul Pharmacol 2014; 62 (1): 32-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).